scholarly journals Barriers and Enablers That Influence Utilization of Ultrasound Screening Services among Antenatal Women in Kajiado and Kisii Counties Kenya

2021 ◽  
Vol 11 (01) ◽  
pp. 1-17
Author(s):  
Micah Matiang’i ◽  
Koen Joosse ◽  
Priscillah Ngunju ◽  
Colleta Kiilu ◽  
Romy Harkx ◽  
...  
PLoS ONE ◽  
2019 ◽  
Vol 14 (4) ◽  
pp. e0198979 ◽  
Author(s):  
Mapa Mudiyanselage Prabhath Nishantha Piyasena ◽  
Gudlavalleti Venkata S. Murthy ◽  
Jennifer L. Y. Yip ◽  
Clare Gilbert ◽  
Maria Zuurmond ◽  
...  

2018 ◽  
Author(s):  
M.M. Prabhath Nishantha Piyasena ◽  
Gudlavalleti Venkata S. Murthy ◽  
Jennifer L.Y. Yip ◽  
Clare Gilbert ◽  
Maria Zuurmond ◽  
...  

AbstractObjectivesThe aim of this systematic review is to identify the barriers/enablers for the people with diabetes (PwDM) in accessing DRS services (DRSS) and challenges/facilitators for the providers.BackgroundDiabetic retinopathy (DR) can lead to visual impairment and blindness if not detected and treated in time. Achievement of an acceptable level of screening coverage is a challenge in any setting. Both patient-related and provider-related factors affect provision of DR screening (DRS) and uptake of services.MethodsWe searched MEDLINE, Embase, CENTRAL in the Cochrane Library from the databases start date to September 2016. We included the studies reported on barriers and enablers to access DRS by PwDM and studies which have assessed barriers or facilitators experienced by the providers in provision of DRSS. We identified and classified the studies that used quantitative or qualitative methods for data collection and analysis in reporting themes of barriers and enablers.Main ResultsWe included 63 studies primarily describing the barriers and enablers. The findings of these studies were based on PwDM from different socio-economic backgrounds and different levels of income settings. Most of the studies were from high income settings (48/63, 76.2%) and cross sectional in design (49/63, 77.8%). From the perspectives of users, lack of knowledge, attitude, awareness and motivation were identified as major barriers to access DRSS. The enablers to access DRSS were fear of blindness, proximity of screening facility, experiences of vision loss and being concerned of eye complications. Providers often mentioned that lack of awareness and knowledge among the PwDM was the main barrier to access. In their perspective lack of skilled human resources, training programs and infrastructure of retinal imaging and cost of services were the main obstacles in provision of screening services.ConclusionKnowing the barriers to access DRS is a pre-requisite in development of a successful screening program. The awareness, knowledge and attitude of the consumers, availability of skilled human resources and infrastructure emerged as the major barriers to access to DRS in any income setting.


2015 ◽  
Vol 218 (02) ◽  
Author(s):  
S Ben Miled ◽  
C Ben Miled ◽  
H Siala ◽  
C Abid-Schlömann ◽  
A Hamdi ◽  
...  

2016 ◽  
Vol 76 (05) ◽  
Author(s):  
F Mraihi ◽  
A Gharsa ◽  
S Schlomann ◽  
A Achour ◽  
D Chelly

2015 ◽  
Vol 54 (03) ◽  
pp. 94-100 ◽  
Author(s):  
P. B. Musholt ◽  
T. J. Musholt

SummaryAim: Thyroid nodules > 1 cm are observed in about 12% of unselected adult employees aged 18–65 years screened by ultrasound scan (40). While intensive ultrasound screening leads to early detection of thyroid diseases, the determination of benign or malignant behaviour remains uncertain and may trigger anxieties in many patients and their physicians. A considerable number of thyroid resections are consecutively performed due to suspicion of malignancy in the detected nodes. Fine needle aspiration biopsy (FNAB) has been recommended for the assessment of thyroid nodules to facilitate detection of thyroid carcinomas but also to rule out malignancy and thereby avoid unnecessary thyroid resections. However, cytology results are dependent on experience of the respective cytologist and unfortunately inconclusive in many cases. Methods: Molecular genetic markers are already used nowadays to enhance sensitivity and specificity of FNAB cytology in some centers in Germany. The most clinically relevant molecular genetic markers as pre-operative diagnostic tools and the clinical implications for the intraoperative and postoperative management were reviewed. Results: Molecular genetic markers predominantly focus on the preoperative detection of thyroid malignancies rather than the exclusion of thyroid carcinomas. While some centers routinely assess FNABs, other centers concentrate on FNABs with cytology results of follicular neoplasia or suspicion of thyroid carcinoma. Predominantly mutations of BRAF, RET/PTC, RAS, and PAX8/PPARγ or expression of miRNAs are analyzed. However, only the detection of BRAF mutations predicts the presence of (papillary) thyroid malignancy with almost 98% probability, indicating necessity of oncologic thyroid resections irrespective of the cytology result. Other genetic alterations are associated with thyroid malignancy with varying frequency and achieve less impact on the clinical management. Conclusion: Molecular genetic analysis of FNABs is increasingly performed in Germany. Standardization, quality controls, and validation of various methods need to be implemented in the near future to be able to compare the results. With increasing knowledge about the impact of genetic alterations on the prognosis of thyroid carcinomas, recommendations have to be defined that may lead to individually optimized treatment strategies.


Author(s):  
D Burdan ◽  
D Teodorescu ◽  
A Marta ◽  
M Satmarean ◽  
E Gomoi ◽  
...  

Chirurgia ◽  
2020 ◽  
Vol 33 (1) ◽  
Author(s):  
Asaf Rabin ◽  
Rana Afifi ◽  
Liana Fahoum ◽  
Sigalit Rappaport ◽  
Ron Karmeli

Sign in / Sign up

Export Citation Format

Share Document